BR112022010204A2 - Derivado do anel de piridina fusionado, método de preparação para o mesmo e uso farmacêutico do mesmo - Google Patents

Derivado do anel de piridina fusionado, método de preparação para o mesmo e uso farmacêutico do mesmo

Info

Publication number
BR112022010204A2
BR112022010204A2 BR112022010204A BR112022010204A BR112022010204A2 BR 112022010204 A2 BR112022010204 A2 BR 112022010204A2 BR 112022010204 A BR112022010204 A BR 112022010204A BR 112022010204 A BR112022010204 A BR 112022010204A BR 112022010204 A2 BR112022010204 A2 BR 112022010204A2
Authority
BR
Brazil
Prior art keywords
preparation
pyridine ring
fusioned
pharmaceutical use
ring derivative
Prior art date
Application number
BR112022010204A
Other languages
English (en)
Inventor
Zhang Xiaomin
Hu Weimin
He Feng
Ye Chaobaihui
Original Assignee
Jiangsu Hengrui Medicine Co
Shanghai hengrui pharmaceutical co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co, Shanghai hengrui pharmaceutical co ltd filed Critical Jiangsu Hengrui Medicine Co
Publication of BR112022010204A2 publication Critical patent/BR112022010204A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADO DO ANEL DE PIRIDINA FUSIONADO, MÉTODO DE PREPARAÇÃO PARA O MESMO E USO FARMACÊUTICO DO MESMO. Trata-se de um derivado do anel de piridina fusionado representado pela fórmula geral (I), um método de preparação para o mesmo, uma composição farmacêutica contendo o derivado e um uso do mesmo como agente terapêutico, particularmente, na preparação de fármacos para prevenir e/ou tratar infecção por HIV.
BR112022010204A 2019-11-29 2020-11-27 Derivado do anel de piridina fusionado, método de preparação para o mesmo e uso farmacêutico do mesmo BR112022010204A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201911198968 2019-11-29
CN202010104095 2020-02-20
CN202010500013 2020-06-04
CN202010656009 2020-07-09
PCT/CN2020/132026 WO2021104413A1 (zh) 2019-11-29 2020-11-27 稠合吡啶环衍生物、其制备方法及其在医药上的应用

Publications (1)

Publication Number Publication Date
BR112022010204A2 true BR112022010204A2 (pt) 2022-09-06

Family

ID=76129126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022010204A BR112022010204A2 (pt) 2019-11-29 2020-11-27 Derivado do anel de piridina fusionado, método de preparação para o mesmo e uso farmacêutico do mesmo

Country Status (11)

Country Link
US (1) US20230023968A1 (pt)
EP (1) EP4067349A4 (pt)
JP (1) JP2023503672A (pt)
KR (1) KR20220108086A (pt)
CN (1) CN114929685B (pt)
AU (1) AU2020390305A1 (pt)
BR (1) BR112022010204A2 (pt)
CA (1) CA3162126A1 (pt)
MX (1) MX2022006489A (pt)
TW (1) TW202128660A (pt)
WO (1) WO2021104413A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313584A (zh) 2021-05-28 2023-04-01 大陸商江蘇恒瑞醫藥股份有限公司 稠合吡啶環衍生物的可藥用鹽、晶型及其製備方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035076A1 (en) * 2001-10-26 2003-05-01 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
JP6205354B2 (ja) 2011-07-06 2017-09-27 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖの処置のための化合物
TW201443037A (zh) 2013-01-09 2014-11-16 Gilead Sciences Inc 治療用化合物
TWI694071B (zh) 2013-03-01 2020-05-21 美商基利科學股份有限公司 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
PT3186239T (pt) * 2014-08-29 2019-01-10 Gilead Sciences Inc Agentes antirretrovirais
PE20190910A1 (es) * 2016-08-19 2019-06-26 Gilead Sciences Inc Compuestos terapeuticos utiles para el tratamiento profilactico o terapeutico de una infeccion por el virus del vih
TW201906834A (zh) 2017-05-02 2019-02-16 英商Viiv醫療保健英國(No.5)有限公司 人類免疫不全病毒複製之抑制劑
AR112413A1 (es) 2017-08-17 2019-10-23 Gilead Sciences Inc Formas sólidas de un inhibidor de la cápside del vih
WO2019161017A1 (en) 2018-02-15 2019-08-22 Gilead Sciences, Inc. Pyridine derivatives and their use for treating hiv infection

Also Published As

Publication number Publication date
CN114929685A (zh) 2022-08-19
MX2022006489A (es) 2022-07-04
CN114929685B (zh) 2023-12-12
WO2021104413A1 (zh) 2021-06-03
EP4067349A1 (en) 2022-10-05
EP4067349A4 (en) 2022-12-21
KR20220108086A (ko) 2022-08-02
CA3162126A1 (en) 2021-06-03
AU2020390305A1 (en) 2022-07-07
US20230023968A1 (en) 2023-01-26
TW202128660A (zh) 2021-08-01
JP2023503672A (ja) 2023-01-31

Similar Documents

Publication Publication Date Title
CL2017001932A1 (es) Dinucleotidos cíclicos útiles para el tratamiento de cancer entre otros.
BR112018068748A2 (pt) composto, composição farmacêutica e de vacina, métodos para indução ou promoção de uma resposta imunológica, para tratamento de câncer, de doenças infecciosas, de distúrbios imunológicos e de doenças imunológicas e para tratamento ou prevenção de uma doença, e, uso de um composto
CO2019013042A2 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
BR112015022096A8 (pt) compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos
CO2019010295A2 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
BR112018077015A2 (pt) derivados de ácido borônico e usos terapêuticos dos mesmos
CO2019010292A2 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
BR112014018990A8 (pt) Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção
ECSP18073293A (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue
CO2019012035A2 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
ECSP18073366A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
BR112015028879A8 (pt) compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos
BR112015014458A8 (pt) compostos derivados de manose, seus intermediários, composição, uso e processos de preparação
BR112015016793A2 (pt) compostos de tiazolacarboxamidas e piridinacarbo-xamida úteis como inibidores de quinase pim
BR112017010645A2 (pt) derivados da piridinocarboxamida, método de preparação dos mesmos e usos farmacêuticos dos mesmos
BR112023006024A2 (pt) Terapias de imuno-oncologia com conjugados de il-2
BR112021017957A2 (pt) Derivado tienoeterocíclico, método de preparação do mesmo e uso médico do mesmo
BR112022010204A2 (pt) Derivado do anel de piridina fusionado, método de preparação para o mesmo e uso farmacêutico do mesmo
BR112015023806A2 (pt) Novos regimes de dosagem de celgosivir para o tratamento de dengue
BR112018013408A2 (pt) derivados de c-glicosídeo que têm anel fenila fusionado ou sais farmaceuticamente aceitáveis dos mesmos, método para preparar os mesmos e composição farmacêutica compreendendo os mesmos
BR112018003181A2 (pt) composto, composição, e, método para tratar infecção por hiv
BR112018002678A2 (pt) composto, composição, e, método para tratar infecção por hiv
PH12018501563A1 (en) Indane derivatives as mglur7 modulators
EA201992804A1 (ru) Производные аминогликозида и их применение при лечении генетических заболеваний
BR112018002681A2 (pt) ?composto, composição, e, método para tratamento de infecção por hiv?

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]